Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.